Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Aethlon Medical (AEMD) EBIT Margin (2016 - 2023)

Aethlon Medical (AEMD) has disclosed EBIT Margin for 13 consecutive years, with 431.51% as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, EBIT Margin rose 2843170.0% year-over-year to 431.51%, compared with a TTM value of 2199.15% through Dec 2023, up 9850607.0%, and an annual FY2025 reading of 200.49%, changed N/A over the prior year.
  • EBIT Margin was 431.51% for Q1 2023 at Aethlon Medical, up from 28863.21% in the prior quarter.
  • Across five years, EBIT Margin topped out at 211.97% in Q4 2019 and bottomed at 28863.21% in Q1 2022.
  • Average EBIT Margin over 5 years is 5679.0%, with a median of 1590.14% recorded in 2021.
  • The sharpest move saw EBIT Margin tumbled -2224590bps in 2022, then soared 2843170bps in 2023.
  • Year by year, EBIT Margin stood at 211.97% in 2019, then crashed by -85bps to 391.18% in 2020, then crashed by -3675bps to 14768.63% in 2021, then tumbled by -95bps to 28863.21% in 2022, then soared by 99bps to 431.51% in 2023.
  • Business Quant data shows EBIT Margin for AEMD at 431.51% in Q1 2023, 28863.21% in Q1 2022, and 14768.63% in Q4 2021.